Resmed (RSMDF) Operating Leases (2019 - 2026)

Resmed (RSMDF) has reported Operating Leases for 8 consecutive years, with $166.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases rose 8.85% year-over-year to $166.6 million; the trailing twelve-month figure through Jun 2026 stood at $166.6 million (up 8.85% YoY), and the FY2026 full-year result was $166.6 million, up 8.85% from the prior year.
• Operating Leases climbed to $166.6 million in Q2 2026 per RSMDF's latest filing, from $149.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $166.6 million in Q2 2026 and bottomed at $112.4 million in Q3 2023.
• Historically, Operating Leases has averaged $135.2 million across 5 years, with a median of $138.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Leases decreased 12.43% in 2022, then climbed 28.49% in 2024.
• Over 5 years, Operating Leases stood at $116.4 million in 2022, then gained by 20.79% to $140.6 million in 2023, then dropped by 1.06% to $139.2 million in 2024, then increased by 10.76% to $154.1 million in 2025, then increased by 8.06% to $166.6 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $166.6 million, $149.8 million, and $154.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.